Pnc Financial Services Group, Inc. Zentalis Pharmaceuticals, Inc. Transaction History
Pnc Financial Services Group, Inc.
- $148 Billion
- Q4 2024
A detailed history of Pnc Financial Services Group, Inc. transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 150 shares of ZNTL stock, worth $288. This represents 0.0% of its overall portfolio holdings.
Number of Shares
150
Previous 22
581.82%
Holding current value
$288
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding ZNTL
# of Institutions
138Shares Held
67.7MCall Options Held
48.5KPut Options Held
89.6K-
Matrix Capital Management Company, LP Waltham, MA14MShares$26.8 Million2.45% of portfolio
-
Eventide Asset Management, LLC Boston, MA8.55MShares$16.4 Million0.55% of portfolio
-
Black Rock Inc. New York, NY4.82MShares$9.25 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.61MShares$8.86 Million0.0% of portfolio
-
Decheng Capital LLC Menlo Park, CA3.11MShares$5.97 Million2.71% of portfolio
About Zentalis Pharmaceuticals, Inc.
- Ticker ZNTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,983,600
- Market Cap $109M
- Description
- Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...